Fariba Goodarzian, MD

Title(s)Associate Professor of Clinical Radiology
SchoolKeck School of Medicine of Usc
AddressCHL Mail Stop 81
Off Campus
Los Angeles CA 90089
Phone+1 323 361 4162
vCardDownload vCard

    Collapse Overview 

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Designing a new sustainable Test Kit supply chain network utilizing Internet of Things. Eng Appl Artif Intell. 2023 Sep; 124:106585. Navaei A, Taleizadeh AA, Goodarzian F. PMID: 37362906; PMCID: PMC10282662.
      View in: PubMed   Mentions:
    2. Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results. Nat Med. 2023 05; 29(5):1092-1102. Goldsmith KC, Park JR, Kayser K, Malvar J, Chi YY, Groshen SG, Villablanca JG, Krytska K, Lai LM, Acharya PT, Goodarzian F, Pawel B, Shimada H, Ghazarian S, States L, Marshall L, Chesler L, Granger M, Desai AV, Mody R, Morgenstern DA, Shusterman S, Macy ME, Pinto N, Schleiermacher G, Vo K, Thurm HC, Chen J, Liyanage M, Peltz G, Matthay KK, Berko ER, Maris JM, Marachelian A, Mossé YP. PMID: 37012551; PMCID: PMC10202811.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    3. Evaluating the efficiency of relief centers in disaster and epidemic conditions using multi-criteria decision-making methods and GIS: A case study. Int J Disaster Risk Reduct. 2023 Feb 01; 85:103512. Choukolaei HA, Ghasemi P, Goodarzian F. PMID: 36589677; PMCID: PMC9791142.
      View in: PubMed   Mentions: 3  
    4. A sustainable-circular citrus closed-loop supply chain configuration: Pareto-based algorithms. J Environ Manage. 2022 Dec 16; 328:116892. Goodarzian F, Ghasemi P, Santibanez Gonzalez ED, Tirkolaee EB. PMID: 36529005.
      View in: PubMed   Mentions:    Fields:    
    5. A new vaccine supply chain network under COVID-19 conditions considering system dynamic: Artificial intelligence algorithms. Socioecon Plann Sci. 2022 Aug 08; 101378. Kamran MA, Kia R, Goodarzian F, Ghasemi P. PMID: 35966449; PMCID: PMC9359548.
      View in: PubMed   Mentions: 4  
    6. A possibilistic-robust-fuzzy programming model for designing a game theory based blood supply chain network. Appl Math Model. 2022 Dec; 112:282-303. Ghasemi P, Goodarzian F, Abraham A, Khanchehzarrin S. PMID: 35946032; PMCID: PMC9352651.
      View in: PubMed   Mentions: 1  
    7. A new humanitarian relief logistic network for multi-objective optimization under stochastic programming. Appl Intell (Dordr). 2022; 52(12):13729-13762. Ghasemi P, Goodarzian F, Abraham A. PMID: 35677730; PMCID: PMC9163870.
      View in: PubMed   Mentions:
    8. Investigating a Dual-Channel Network in a Sustainable Closed-Loop Supply Chain Considering Energy Sources and Consumption Tax. Sensors (Basel). 2022 May 06; 22(9). Gharye Mirzaei M, Goodarzian F, Maddah S, Abraham A, Abdelkareim Gabralla L. PMID: 35591237; PMCID: PMC9103749.
      View in: PubMed   Mentions:    Fields:    
    9. Designing an integrated responsive-green-cold vaccine supply chain network using Internet-of-Things: artificial intelligence-based solutions. Ann Oper Res. 2022 May 05; 1-45. Goodarzian F, Navaei A, Ehsani B, Ghasemi P, Muñuzuri J. PMID: 35540307; PMCID: PMC9071011.
      View in: PubMed   Mentions: 2  
    10. Designing a new multi-echelon multi-period closed-loop supply chain network by forecasting demand using time series model: a genetic algorithm. Environ Sci Pollut Res Int. 2022 Nov; 29(53):79754-79768. Safaei S, Ghasemi P, Goodarzian F, Momenitabar M. PMID: 35244850.
      View in: PubMed   Mentions: 4     Fields:    Translation:PHPublic Health
    11. Designing a sustainable closed-loop supply chain network of face masks during the COVID-19 pandemic: Pareto-based algorithms. J Clean Prod. 2022 Jan 20; 333:130056. Tirkolaee EB, Goli A, Ghasemi P, Goodarzian F. PMID: 34924699; PMCID: PMC8671674.
      View in: PubMed   Mentions: 18  
    12. Imaging of congenital genitourinary anomalies. Pediatr Radiol. 2022 Apr; 52(4):726-739. Acharya PT, Ponrartana S, Lai L, Vasquez E, Goodarzian F. PMID: 34741177.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. A sustainable-resilience healthcare network for handling COVID-19 pandemic. Ann Oper Res. 2022; 312(2):761-825. Goodarzian F, Ghasemi P, Gunasekaren A, Taleizadeh AA, Abraham A. PMID: 34642527; PMCID: PMC8497050.
      View in: PubMed   Mentions: 17  
    14. A discrete event simulation method for performance analysis of an additive manufacturing in the dental clinic. Int J Adv Manuf Technol. 2022; 118(9-10):2949-2979. Kamali AH, Moradi M, Goodarzian F, Ghasemi P. PMID: 34642530; PMCID: PMC8495446.
      View in: PubMed   Mentions: 1  
    15. Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium. J Clin Oncol. 2021 11 01; 39(31):3506-3514. DuBois SG, Granger MM, Groshen S, Tsao-Wei D, Ji L, Shamirian A, Czarnecki S, Goodarzian F, Berkovich R, Shimada H, Villablanca JG, Vo KT, Pinto N, Mosse YP, Maris JM, Shusterman S, Cohn SL, Goldsmith KC, Weiss B, Yanik GA, Twist CJ, Irwin MS, Haas-Kogan DA, Park JR, Marachelian A, Matthay KK. PMID: 34270348; PMCID: PMC8547934.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    16. An integrated sustainable medical supply chain network during COVID-19. Eng Appl Artif Intell. 2021 Apr; 100:104188. Goodarzian F, Taleizadeh AA, Ghasemi P, Abraham A. PMID: 33619424; PMCID: PMC7890303.
      View in: PubMed   Mentions: 30  
    17. Clinical management and recommendations for children with more than four episodes of recurrent intussusception following successful reduction of each: an institutional review. Clin Radiol. 2020 11; 75(11):864-867. Hutchason A, Sura A, Vettikattu N, Goodarzian F. PMID: 32896426.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Premature epiphyseal growth plate arrest after isotretinoin therapy for high-risk neuroblastoma: A case series and review of the literature. Pediatr Blood Cancer. 2020 08; 67(8):e28236. Duvalyan A, Cha A, Goodarzian F, Arkader A, Villablanca JG, Marachelian A. PMID: 32386124.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    19. A bi-objective home healthcare routing and scheduling problem considering patients' satisfaction in a fuzzy environment. Appl Soft Comput. 2020 Aug; 93:106385. Fathollahi-Fard AM, Ahmadi A, Goodarzian F, Cheikhrouhou N. PMID: 32395097; PMCID: PMC7205736.
      View in: PubMed   Mentions: 11  
    20. Absence of Testicular Adrenal Rest Tumors in Newborns, Infants, and Toddlers with Classical Congenital Adrenal Hyperplasia. Horm Res Paediatr. 2019; 92(3):157-161. Kim MS, Koppin CM, Mohan P, Goodarzian F, Ross HM, Geffner ME, De Filippo R, Kokorowski P. PMID: 31747670; PMCID: PMC7004842.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    21. Ensuring Appropriateness of Pediatric Second Opinion Consultations. Curr Probl Diagn Radiol. 2020 Mar - Apr; 49(2):82-84. Glavis-Bloom J, Yang U, Nahl D, Goodarzian F, Sura A. PMID: 31147095.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma. Clin Cancer Res. 2018 12 15; 24(24):6142-6149. DuBois SG, Mosse YP, Fox E, Kudgus RA, Reid JM, McGovern R, Groshen S, Bagatell R, Maris JM, Twist CJ, Goldsmith K, Granger MM, Weiss B, Park JR, Macy ME, Cohn SL, Yanik G, Wagner LM, Hawkins R, Courtier J, Lai H, Goodarzian F, Shimada H, Boucher N, Czarnecki S, Luo C, Tsao-Wei D, Matthay KK, Marachelian A. PMID: 30093449; PMCID: PMC6295246.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCTClinical Trials
    23. The Utility of Cranial Ultrasound for Detection of Intracranial Hemorrhage in Infants. Pediatr Emerg Care. 2018 Feb; 34(2):96-101. Elkhunovich M, Sirody J, McCormick T, Goodarzian F, Claudius I. PMID: 26999586.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    24. Predictors of response, progression-free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high-risk neuroblastoma. Pediatr Blood Cancer. 2018 05; 65(5):e26940. Villablanca JG, Ji L, Shapira-Lewinson A, Marachelian A, Shimada H, Hawkins RA, Pampaloni M, Lai H, Goodarzian F, Sposto R, Park JR, Matthay KK. PMID: 29350464; PMCID: PMC7456604.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    25. Improving Pediatric Breast Ultrasound Reporting and Recommendations. J Am Coll Radiol. 2017 11; 14(11):1451-1454. Luhar AP, Chiang M, Langer J, Gupta E, Goodarzian F, Sura A. PMID: 28601612.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis. Clin Cancer Res. 2017 Sep 15; 23(18):5374-5383. Marachelian A, Villablanca JG, Liu CW, Liu B, Goodarzian F, Lai HA, Shimada H, Tran HC, Parra JA, Gallego R, Bedrossian N, Young S, Czarnecki S, Kennedy R, Weiss BD, Goldsmith K, Granger M, Matthay KK, Groshen S, Asgharzadeh S, Sposto R, Seeger RC. PMID: 28559462.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    27. Testicular Adrenal Rest Tumors in Boys and Young Adults with Congenital Adrenal Hyperplasia. J Urol. 2017 03; 197(3 Pt 2):931-936. Kim MS, Goodarzian F, Keenan MF, Geffner ME, Koppin CM, De Filippo RE, Kokorowski PJ. PMID: 27840017; PMCID: PMC5449264.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    28. A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma. Pediatr Blood Cancer. 2016 08; 63(8):1349-56. Villablanca JG, Volchenboum SL, Cho H, Kang MH, Cohn SL, Anderson CP, Marachelian A, Groshen S, Tsao-Wei D, Matthay KK, Maris JM, Hasenauer CE, Czarnecki S, Lai H, Goodarzian F, Shimada H, Reynolds CP. PMID: 27092812; PMCID: PMC8992729.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCellsCTClinical Trials
    29. Intravenous Fluid Bolus Prior to Neonatal and Infant Lumbar Puncture: A Sonographic Assessment of the Subarachnoid Space After Intravenous Fluid Administration. JAMA Pediatr. 2016 Mar; 170(3):e154636. Rankin J, Wang VJ, Goodarzian F, Lai HA. PMID: 26954534.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    30. Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial. J Clin Oncol. 2016 Apr 20; 34(12):1368-75. DuBois SG, Marachelian A, Fox E, Kudgus RA, Reid JM, Groshen S, Malvar J, Bagatell R, Wagner L, Maris JM, Hawkins R, Courtier J, Lai H, Goodarzian F, Shimada H, Czarnecki S, Tsao-Wei D, Matthay KK, Mosse YP. PMID: 26884555; PMCID: PMC4872349.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCTClinical Trials
    31. Radiographic depiction of intra-abdominal fat in newborns: a marker of infants born to diabetic mothers. J Perinatol. 2016 05; 36(5):389-91. Ponrartana S, Goodarzian F, Emadi S, Aggabao PC, Fisher CL, Gilsanz V. PMID: 26765553.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. Pilot Feasibility Study of Comprehensive Pulmonary Evaluation Following Lung Radiation Therapy. J Pediatr Hematol Oncol. 2015 Oct; 37(7):e412-8. De A, Mascarenhas L, Kamath S, LaRiviere A, Goodarzian F, Keens TG, Venkatramani R. PMID: 26241727; PMCID: PMC4573838.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    33. Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma. Clin Cancer Res. 2015 Jun 15; 21(12):2715-21. DuBois SG, Groshen S, Park JR, Haas-Kogan DA, Yang X, Geier E, Chen E, Giacomini K, Weiss B, Cohn SL, Granger MM, Yanik GA, Hawkins R, Courtier J, Jackson H, Goodarzian F, Shimada H, Czarnecki S, Tsao-Wei D, Villablanca JG, Marachelian A, Matthay KK. PMID: 25695691; PMCID: PMC4470833.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCellsCTClinical Trials
    34. 131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II study. Biol Blood Marrow Transplant. 2015 Apr; 21(4):673-81. Yanik GA, Villablanca JG, Maris JM, Weiss B, Groshen S, Marachelian A, Park JR, Tsao-Wei D, Hawkins R, Shulkin BL, Jackson H, Goodarzian F, Shimada H, Courtier J, Hutchinson R, Haas-Koga D, Hasenauer CB, Czarnecki S, Katzenstein HM, Matthay KK. PMID: 25639769.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    35. Pulmonary outcomes in patients with Hodgkin lymphoma treated with involved field radiation. Pediatr Blood Cancer. 2014 Jul; 61(7):1277-81. Venkatramani R, Kamath S, Wong K, Olch AJ, Malvar J, Sposto R, Goodarzian F, Freyer DR, Keens TG, Mascarenhas L. PMID: 24482138.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    36. An infant with an ectopic torsed testis in the abdominal wall. Emerg Radiol. 2014 Apr; 21(2):223-5. Andrade K, Smith S, Goodarzian F. PMID: 24275899.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    37. Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: a report from the New Approaches to Neuroblastoma Therapy (NANT) consortium. Pediatr Blood Cancer. 2013 Nov; 60(11):1801-8. Maurer BJ, Kang MH, Villablanca JG, Janeba J, Groshen S, Matthay KK, Sondel PM, Maris JM, Jackson HA, Goodarzian F, Shimada H, Czarnecki S, Hasenauer B, Reynolds CP, Marachelian A. PMID: 23813912; PMCID: PMC4066886.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCTClinical Trials
    38. Correlation of clinical and dosimetric factors with adverse pulmonary outcomes in children after lung irradiation. Int J Radiat Oncol Biol Phys. 2013 Aug 01; 86(5):942-8. Venkatramani R, Kamath S, Wong K, Olch AJ, Malvar J, Sposto R, Goodarzian F, Freyer DR, Keens TG, Mascarenhas L. PMID: 23726005.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    39. Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial. J Nucl Med. 2012 Jul; 53(7):1155-63. Matthay KK, Weiss B, Villablanca JG, Maris JM, Yanik GA, Dubois SG, Stubbs J, Groshen S, Tsao-Wei D, Hawkins R, Jackson H, Goodarzian F, Daldrup-Link H, Panigrahy A, Towbin A, Shimada H, Barrett J, Lafrance N, Babich J. PMID: 22700000.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    40. The depiction of brown adipose tissue is related to disease status in pediatric patients with lymphoma. AJR Am J Roentgenol. 2012 Apr; 198(4):909-13. Gilsanz V, Hu HH, Smith ML, Goodarzian F, Carcich SL, Warburton NM, Malogolowkin M. PMID: 22451560.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    41. Inverse association between brown adipose tissue activation and white adipose tissue accumulation in successfully treated pediatric malignancy. Am J Clin Nutr. 2012 May; 95(5):1144-9. Chalfant JS, Smith ML, Hu HH, Dorey FJ, Goodarzian F, Fu CH, Gilsanz V. PMID: 22456659; PMCID: PMC3325837.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    42. Phase I study of vincristine, irinotecan, and ¹³¹I-metaiodobenzylguanidine for patients with relapsed or refractory neuroblastoma: a new approaches to neuroblastoma therapy trial. Clin Cancer Res. 2012 May 01; 18(9):2679-86. DuBois SG, Chesler L, Groshen S, Hawkins R, Goodarzian F, Shimada H, Yanik G, Tagen M, Stewart C, Mosse YP, Maris JM, Tsao-Wei D, Marachelian A, Villablanca JG, Matthay KK. PMID: 22421195; PMCID: PMC6814395.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    43. Changes in brown adipose tissue in boys and girls during childhood and puberty. J Pediatr. 2012 Apr; 160(4):604-609.e1. Gilsanz V, Smith ML, Goodarzian F, Kim M, Wren TA, Hu HH. PMID: 22048045; PMCID: PMC3307823.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    See more options in the Advanced Search tab

    Fariba's Networks
    Concepts (187)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (26)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.